Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Atara Biotherap (ATRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,072,794
  • Shares Outstanding, K 46,321
  • Annual Sales, $ 0 K
  • Annual Income, $ -230,700 K
  • 60-Month Beta 2.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -1.46
  • Number of Estimates 3
  • High Estimate -1.44
  • Low Estimate -1.49
  • Prior Year -1.15
  • Growth Rate Est. (year over year) -26.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.00 +0.70%
on 05/22/19
36.55 -36.63%
on 05/06/19
-8.53 (-26.92%)
since 04/22/19
3-Month
23.00 +0.70%
on 05/22/19
41.97 -44.82%
on 02/26/19
-15.42 (-39.97%)
since 02/22/19
52-Week
23.00 +0.70%
on 05/22/19
52.74 -56.09%
on 05/25/18
-27.24 (-54.05%)
since 05/22/18

Most Recent Stories

More News
Atara Biotherape Has Returned 34.5% Since SmarTrend Recommendation (ATRA)

SmarTrend identified a Downtrend for Atara Biotherape (NASDAQ:ATRA) on April 11th, 2019 at $36.65. In approximately 1 month, Atara Biotherape has returned 34.52% as of today's recent price of $24.00.

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics Announces Presentations Highlighting Tab-cel(R) and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced...

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics Announces Presentation of Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced...

ATRA : 23.16 (-4.97%)
Atara Biotherape Shares Down 28.5% Since SmarTrend's Sell Call (ATRA)

SmarTrend identified a Downtrend for Atara Biotherape (NASDAQ:ATRA) on April 11th, 2019 at $36.65. In approximately 4 weeks, Atara Biotherape has returned 28.46% as of today's recent price of $26.22.

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics: 1Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Thursday reported a loss of $66.3 million in its first quarter.

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics Announces First Quarter 2019 Financial Results and Recent Operational Progress

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported...

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Atara Biotherapeutics, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 9, 2019 at 8:30 AM Eastern...

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced...

ATRA : 23.16 (-4.97%)
Watch for Atara Biotherape to Potentially Pullback After Gaining 1.89% Yesterday

Atara Biotherape (NASDAQ:ATRA) traded in a range yesterday that spanned from a low of $33.84 to a high of $34.76. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high...

ATRA : 23.16 (-4.97%)
Atara Biotherapeutics is Now Oversold (ATRA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

ATRA : 23.16 (-4.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ATRA with:

Business Summary

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta...

See More

Key Turning Points

2nd Resistance Point 25.01
1st Resistance Point 24.09
Last Price 23.16
1st Support Level 22.62
2nd Support Level 22.07

See More

52-Week High 52.74
Fibonacci 61.8% 41.38
Fibonacci 50% 37.87
Fibonacci 38.2% 34.36
Last Price 23.16
52-Week Low 23.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar